Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 2
2015 3
2016 1
2019 3
2020 4
2021 1
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Cold Tumors: A Therapeutic Challenge for Immunotherapy.
Bonaventura P, Shekarian T, Alcazer V, Valladeau-Guilemond J, Valsesia-Wittmann S, Amigorena S, Caux C, Depil S. Bonaventura P, et al. Among authors: valladeau guilemond j. Front Immunol. 2019 Feb 8;10:168. doi: 10.3389/fimmu.2019.00168. eCollection 2019. Front Immunol. 2019. PMID: 30800125 Free PMC article. Review.
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy.
Bonaventura P, Alcazer V, Mutez V, Tonon L, Martin J, Chuvin N, Michel E, Boulos RE, Estornes Y, Valladeau-Guilemond J, Viari A, Wang Q, Caux C, Depil S. Bonaventura P, et al. Among authors: valladeau guilemond j. Sci Adv. 2022 Jan 28;8(4):eabj3671. doi: 10.1126/sciadv.abj3671. Epub 2022 Jan 26. Sci Adv. 2022. PMID: 35080970 Free PMC article.
Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methods.
Bayerl F, Bejarano DA, Bertacchi G, Doffin AC, Gobbini E, Hubert M, Li L, Meiser P, Pedde AM, Posch W, Rupp L, Schlitzer A, Schmitz M, Schraml BU, Uderhardt S, Valladeau-Guilemond J, Wilflingseder D, Zaderer V, Böttcher JP. Bayerl F, et al. Among authors: valladeau guilemond j. Eur J Immunol. 2023 Nov;53(11):e2249923. doi: 10.1002/eji.202249923. Epub 2023 Jan 9. Eur J Immunol. 2023. PMID: 36623939
Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients.
Sosa Cuevas E, Valladeau-Guilemond J, Mouret S, Roubinet B, de Fraipont F, Landemarre L, Charles J, Bendriss-Vermare N, Chaperot L, Aspord C. Sosa Cuevas E, et al. Among authors: valladeau guilemond j. Front Immunol. 2022 Oct 24;13:1040600. doi: 10.3389/fimmu.2022.1040600. eCollection 2022. Front Immunol. 2022. PMID: 36353633 Free PMC article.
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer.
Hubert M, Gobbini E, Couillault C, Manh TV, Doffin AC, Berthet J, Rodriguez C, Ollion V, Kielbassa J, Sajous C, Treilleux I, Tredan O, Dubois B, Dalod M, Bendriss-Vermare N, Caux C, Valladeau-Guilemond J. Hubert M, et al. Among authors: valladeau guilemond j. Sci Immunol. 2020 Apr 17;5(46):eaav3942. doi: 10.1126/sciimmunol.aav3942. Epub 2020 Apr 17. Sci Immunol. 2020. PMID: 32303573
21 results